On September 12, 2022, President Biden signed the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy. The objective of ...

As part of the National Biotechnology and Biomanufacturing Initiative, the U.S. Department of Defense (DOD) announced in September 2022 an investment of $1.2 billion in bioindustrial domestic ...

Our planet faces an urgent environmental and social crisis, but hope could be on the horizon. Biomanufacturing offers a revolutionary solution for improving the sustainability and responsibility of ...

Biologics manufacturing is entering a new phase where agility and proximity matter as much as scale. For decades, the industry relied on the philosophy that “bigger is better,” constructing massive, ...

Biomanufacturing capacity is at a critically low level for startups and early stage life sciences firms, imperiling the success of new companies and their ideas. At this moment, a confluence of ...

Manufacturing facilities that make the next generation of drugs and therapeutics are seeing a burst of interest across the country, rising from their former status as a niche subset of life sciences ...

Industrial biomanufacturing occupies a distinctive position in the production of high-value specialty chemicals. This article discusses two of the technology trends in specialty chemical ...

The Bioprocess International (BPI) meeting kicked off on Tuesday morning with an opening plenary session led by Sarah Glaven, PhD, principal assistant director of biotechnology and biomanufacturing at ...

March 22 (UPI) --The Department of Defense on Wednesday released its biomanufacturing strategy, saying the issue carries "significant implications for national security and economic competitiveness." ...

Aberdeen Proving Ground, MD --When the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) expanded the size and capabilities of its biomanufacturing hub at its ...